Cited by 187RNA and protein synthesis mechanismsPI3K/AKT/mTOR signaling in cancerCancer-related Molecular Pathways

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

The Role of Myc-Induced Protein Synthesis in Cancer

Open access

Ruggero, Davide·2009·Cancer Research

DOI 10.1158/0008-5472.can-09-1970PMC PMC2880919

Open this paper in CoChat — free account Open PDF

Abstract

Deregulation in different steps of translational control is an emerging mechanism for cancer formation. One example of an oncogene with a direct role in control of translation is the Myc transcription factor. Myc directly increases protein synthesis rates by controlling the expression of multiple components of the protein synthetic machinery, including ribosomal proteins and initiation factors of translation, Pol III and rDNA. However, the contribution of Myc-dependent increases in protein synthesis toward the multistep process leading to cancer has remained unknown. Recent evidence strongly suggests that Myc oncogenic signaling may monopolize the translational machinery to elicit cooperative effects on cell growth, cell cycle progression, and genome instability as a mechanism for cancer initiation. Moreover, new genetic tools to restore aberrant increases in protein synthesis control are now available, which should enable the dissection of important mechanisms in cancer that rely on the translational machinery. [Cancer Res 2009;69(23):8839–43]

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-09-1970

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Proliferation, cell cycle and apoptosis in cancer
Evan, G. I., & Vousden, K. H. (2001) · Nature · doi:10.1038/35077213 · Cited by 3,417
The c-Myc target gene network
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188
MYC oncogenes and human neoplastic disease
Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,163
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., & Shokat, K. M. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000038 · Cited by 1,111
Self-citation
Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
Coller, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823
How Common Are Extraribosomal Functions of Ribosomal Proteins?
Warner, J. R., & McIntosh, K. B. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.03.006 · Cited by 735
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
Grandori, C., Gomez-Roman, N., Felton-Edkins, Z. A., Ngouenet, C., Galloway, D. A., Eisenman, R. N., & White, R. J. (2005) · Nature Cell Biology · doi:10.1038/ncb1224 · Cited by 659
Drosophila myc Regulates Cellular Growth during Development
Johnston, L. A., Prober, D. A., Edgar, B. A., Eisenman, R. N., & Gallant, P. (1999) · Cell · doi:10.1016/s0092-8674(00)81512-3 · Cited by 648
dMyc Transforms Cells into Super-Competitors
Moreno, E., & Basler, K. (2004) · Cell · doi:10.1016/s0092-8674(04)00262-4 · Cited by 597
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription
Arabi, A., Wu, S., Ridderstråle, K., Bierhoff, H., Shiue, C.-N., Fátyol, K., Fahlén, S., Hydbring, P., Söderberg, O., Grummt, I., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1225 · Cited by 507

Show all 42 references

Sorted by citations

Items 101–187 of 187

Eukaryotic translation initiation factor 6 overexpression plays a major role in the translational control of gallbladder cancer
Golob‐Schwarzl, N., Wodlej, C., Kleinegger, F., Gogg-Kamerer, M., Birkl-Toeglhofer, A. M., Petzold, J., Aigelsreiter, A., Thalhammer, M., Park, Y. N., & Haybaeck, J. (2019) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-019-03030-x · Cited by 19
Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma
Kling, M. J., Griggs, C. N., McIntyre, E. M., Alexander, G. R., Ray, S., Challagundla, K. B., Joshi, S. S., Coulter, D. W., & Chaturvedi, N. K. (2021) · BMC Cancer · doi:10.1186/s12885-021-08782-9 · Cited by 20
S6 Kinase is essential for MYC-dependent rDNA transcription in Drosophila
Mitchell, N. C., Tchoubrieva, E. B., Chahal, A., Woods, S. J., Lee, A., Lin, J. I., Parsons, L. M., Jastrzebski, K., Poortinga, G., Hannan, K. M., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.07.018 · Cited by 18
HIF‐1α up‐regulation is associated with adverse clinicopathological and biological factors in neuroblastomas
Dungwa, J. V., Hunt, L. P., & Ramani, P. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04227.x · Cited by 17
TGFβ/Activin signalling is required for ribosome biogenesis and cell growth inDrosophilasalivary glands
Martins, T., Eusébio, N., Correia, A., Marinho, J. C. L., Casares, F., & Pereira, P. S. (2017) · Open Biology · doi:10.1098/rsob.160258 · Cited by 16
Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors
Tran, H. M., Wu, K.-S., Sung, S., Changou, C. A., Hsieh, T., Liu, Y., Liu, Y., Tsai, M., Lee, H., Hsieh, K. L., et al. (2020) · Cancers · doi:10.3390/cancers12030752 · Cited by 18
N-myc–Mediated Translation Control Is a Therapeutic Vulnerability in Medulloblastoma
Kuzuoğlu‐Öztürk, D., Aksoy, O., Schmidt, C., Lea, R., Larson, J. D., Phelps, R. R. L., Nasholm, N. M., Holt, M., Contreras, A., Huang, M., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-0945 · Cited by 13
Self-citation
Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma
Scagliola, A., Miluzio, A., & Biffo, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054885 · Cited by 17
Viable mutations of mouse midnolin suppress B cell malignancies
Zhong, X. Y., Peddada, N., Moresco, J. J., Wang, J., Jiang, Y., Rios, J. J., Moresco, E. M. Y., Choi, J. H., & Beutler, B. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232132 · Cited by 15
High-throughput transcriptome profiling indicates ribosomal RNAs to be associated with resistance to immunotherapy in non-small cell lung cancer (NSCLC)
Moutafi, M. K., Bates, K., Aung, T. N., García-Milian, R., Xirou, V., Vathiotis, I. A., Gavrielatou, N., Angelakis, A., Schalper, K. A., Salichos, L., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-009039 · Cited by 17
Mina53, a novel molecular marker for the diagnosis and prognosis of gastric adenocarcinoma
XING, J., WANG, K., LIU, P.-W., Miao, Q., & Chen, X. (2013) · Oncology Reports · doi:10.3892/or.2013.2918 · Cited by 16
Myc in Stem Cell Behaviour: Insights from Drosophila
Quinn, L. M., Secombe, J., & Hime, G. R. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6621-1_15 · Cited by 16
Inducible pluripotent stem cells for the treatment of ischemic stroke: current status and problems
Zhu, Y., Wan, S., & Zhan, R. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0042 · Cited by 16
Heterozygosity of Chaperone Grp78 Reduces Intestinal Stem Cell Regeneration Potential and Protects against Adenoma Formation
de Jeude, J. F. V. L., Spaan, C. N., Meijer, B. J., Smit, W. L., Soeratram, T. T. D., Wielenga, M. C. B., Westendorp, B. F., Lee, A. S., Meisner, S., Vermeulen, J. L. M., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3600 · Cited by 16
The roles of NOP56 in cancer and SCA36
Zhao, S., Zhang, D., Liu, S., & Huang, J. S. (2023) · Pathology & Oncology Research · doi:10.3389/pore.2023.1610884 · Cited by 15
Melatonin Signaling Pathways Implicated in Metabolic Processes in Human Granulosa Cells (KGN)
Arjoune, A., & Sirard, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23062988 · Cited by 16
Gene expression profiling of HGF/Met activation in neonatal mouse heart
Gatti, S., Leo, C., Gallo, S., Sala, V., Bucci, E. M., Natale, M., Cantarella, D., Médico, E., & Crepaldi, T. (2012) · Transgenic Research · doi:10.1007/s11248-012-9667-2 · Cited by 15
Lessons in aging from Myc knockout mouse models
Prochownik, E. V., & Wang, H. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1244321 · Cited by 16
Porcine Circovirus-Like Virus P1 Inhibits Wnt Signaling Pathway in Vivo and in Vitro
Zhu, X., Wen, L., Sheng, S., Wang, W., Xiao, Q., Qu, M., Hu, Y., Liu, C., & He, K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00390 · Cited by 14
Pathogenic Mechanisms and Therapeutic Implication in Nickel-Induced Cell Damage
Salimi, A., Jamali, Z., Atashbar, S., Khezri, S., Ghorbanpour, A. M., & Etefaghi, N. (2020) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530320666200214123118 · Cited by 14
Synthetic molecules for disruption of the MYC protein-protein interface
Jacob, N. T., Miranda, P. O., Shirey, R. J., Gautam, R., Zhou, B., de Orbe, M. E., Hixon, M. S., Hart, J. R., Ueno, L. A., Vogt, P. K., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.07.019 · Cited by 12
Ceftriaxone exerts antitumor effects in MYCN ‐driven retinoblastoma and neuroblastoma by targeting DDX3X for translation repression
Chittavanich, P., Saengwimol, D., Roytrakul, S., Rojanaporn, D., Chaitankar, V., Srimongkol, A., Anurathapan, U., Hongeng, S., & Kaewkhaw, R. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13553 · Cited by 11
Small-molecule SUMO inhibition for biomarker-informed B-cell lymphoma therapy
Demel, U. M., Wirth, M., Yousefian, S., Zhang, L., Isaakidis, K., Dönig, J., Böger, M., Singh, N., Köse, H., Haas, S. F., et al. (2022) · Haematologica · doi:10.3324/haematol.2022.280995 · Cited by 11
MYC function and regulation in flies: how Drosophila has enlightened MYC cancer biology
Lee, J. E. A., Parsons, L. M., & Quinn, L. M. (2014) · Global Medical Genetics · doi:10.3934/genet.2014.1.81 · Cited by 10
Targeting Translation and the Cell Cycle Inversely Affects CTC Metabolism but Not Metastasis
Bowley, T. Y., Merkley, S. D., Lagutina, I. V., Ortiz, M. C., Lee, M., Tawfik, B., & Marchetti, D. (2023) · Cancers · doi:10.3390/cancers15215263 · Cited by 9
Expansion effect of romiplostim on hematopoietic stem and progenitor cells versus thrombopoietin and eltrombopag
Tezuka, Y., Onoda, N., Morishima, T., Sumitomo, Y., Nishii, K., Takizawa, H., & Kai, M. (2024) · International Journal of Hematology · doi:10.1007/s12185-024-03853-6 · Cited by 9
Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons
Qi, S. D., Smith, P. D., & Choong, P. (2012) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2012.06282.x · Cited by 9
Identification and Comparative Analysis of Long Non-coding RNAs in High- and Low-Fecundity Goat Ovaries During Estrus
Li, Y., Xu, X., Deng, M., Zou, X., Zhao, Z., Huang, S., Liu, D., & Liu, G. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.648158 · Cited by 9
Targeting protein synthesis pathways in MYC-amplified medulloblastoma
Kumar, D., Kanchan, R. K., & Chaturvedi, N. K. (2025) · Discover Oncology · doi:10.1007/s12672-025-01761-7 · Cited by 9
The MYC-Regulated RNA-Binding Proteins hnRNPC and LARP1 Are Drivers of Multiple Myeloma Cell Growth and Disease Progression and Negatively Predict Patient Survival
Seibert, M., Koschade, S. E., Stolp, V., Häupl, B., Wempe, F., Serve, H. L., Kurrle, N., Schnütgen, F., & von Metzler, I. (2023) · Cancers · doi:10.3390/cancers15235508 · Cited by 7
Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma
Coulter, D. W., Chhonker, Y. S., Kumar, D., Kesherwani, V., Aldhafiri, W. N., McIntyre, E. M., Alexander, G. R., Ray, S., Joshi, S. S., Li, R., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02944-w · Cited by 7
The Role of Dysregulated MicroRNA Expression in Lung Cancer
Krutakova, M., Šarlinová, M., Matáková, T., Dzian, A., Hamžík, J., Pec, M., Javorkova, S., & Halasova, E. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_219 · Cited by 7
PCV2 inhibits the Wnt signalling pathway in vivo and in vitro
Zhu, X., Wen, L., Wang, W., Xiao, Q., Li, B., & He, K. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108787 · Cited by 7
NOP56 negatively regulates MyD88-mediated NF-κB signaling in miiuy croaker, Miichthys miiuy
Ren, X., Zhang, H., Yan, X., Sun, Y., & Xu, T. (2021) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2021.11.011 · Cited by 7
Context-dependent translation inhibition as a cancer therapeutic modality
Diamond, P. D., Sauer, P. V., Holm, M., Swanson-Swett, C. J., Ferguson, L., Bratset, N. M., Wienker, G. W., Sim, J. S., Adams, H., Kenner, L. R., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-69891-2 · Cited by 9
Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons
Qi, S. D., Smith, P. D., & Choong, P. (2014) · ANZ Journal of Surgery · doi:10.1111/ans.12419 · Cited by 6
Investigating Myc-Dependent Translational Regulation in Normal and Cancer Cells
Cunningham, J. T., Pourdehnad, M., Stumpf, C. R., & Ruggero, D. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-429-6_13 · Cited by 6
Self-citation
Auranofin and reactive oxygen species inhibit protein synthesis and regulate the level of the PLK1 protein in Ewing sarcoma cells
Haight, J. A., Koppenhafer, S. L., Geary, E. L., & Gordon, D. J. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1394653 · Cited by 5
Noninvasive detection of aneuploid cells in laryngeal epithelial precursor lesions
Shani, T., Primov‐Fever, A., Wolf, M., Shalmon, B., Amarglio, N., Trakhtenbrot, L., & Hirshberg, A. (2011) · Cancer Cytopathology · doi:10.1002/cncy.20157 · Cited by 5
A toxicogenomics-based identification of potential mechanisms and signaling pathways involved in PFCs-induced cancer in human
Dehghani, Z., Ranjbar, S., Shahabinezhad, F., Sabouri, P., & Mohammadi‐Bardbori, A. (2024) · Toxicology Research · doi:10.1093/toxres/tfae151 · Cited by 4
mTOR and Regulation of Translation
Tsukumo, Y., Laplante, M., Parsyan, A. E., Ruggero, D., & Fonseca, B. D. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_15 · Cited by 5
Self-citation
Altered transcription and replication are the mechanisms of cytotoxicity of antitumor antibiotic olivomycin A
Cheglakov, I. B., Tevyashova, A. N., Kurbatov, L. K., Tatarskiy, V. V., Samusenko, A. V., PREOBRAZHENSKAYA, M. N., & Shtil, A. A. (2010) · Doklady Biochemistry and Biophysics · doi:10.1134/s1607672910060104 · Cited by 4
The oncoprotein Myc controls the phosphorylation of S6 kinase and AKT through protein phosphatase 2A
Chellini, L., Monteleone, V., Lombari, M., Caldarola, S., & Loreni, F. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27309 · Cited by 4
Myc family proteins: Molecular drivers of tumorigenesis and resistance in neuroendocrine tumors
Hylton-McComas, H. M., Cordes, A. F., Floros, K. V., Faber, A. C., Drapkin, B. J., & Miles, W. O. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189332 · Cited by 3
Non-Canonical, Strongly Selective Protein Disulfide Isomerases as Anticancer Therapeutic Targets
Law, M. E., Dulloo, Z. M., Hardy, B. P., Kelegama, A., Clark, R., Montbrun, M. R., Antmann, G., Nooka, S., Castellano, R. K., & Law, B. K. (2025) · Biomolecules · doi:10.3390/biom15081146 · Cited by 3
Nucleolus as a cornerstone linking proliferation and metabolism to cellular responses to stress: involvement of transcription factors MYC and p53
Moraleva, A. A., Антипова, Н. В., Pavlov, P., Dobrochaeva, K. L., & Rubtsov, Y. P. (2026) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2026.1749992 · Cited by 4
MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer
Zheng, S. M., Feng, Y., Zhu, Q. Y., Li, R. Q., Yan, Q. Q., Teng, L., Yue, Y. M., Han, M. M., Ye, K., Zhang, S. N., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-3046 · Cited by 3
Identification of Key mRNAs and lncRNAs Associated with the Effects of Anti-TWEAK on Osteosarcoma
Yang, M., Zhao, L., Hu, X., Feng, H., & Kang, X. (2020) · Current Bioinformatics · doi:10.2174/1574893615999200626191405 · Cited by 3
Corrections for mRNA extraction and sample normalization errors find increased mRNA levels may compensate for cancer haplo‐insufficiency
Weaver, D. A., Nestor‐Kalinoski, A. L., Craig, K., Gorris, M. A., Parikh, T., Mabry, H., & Allison, D. C. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22133 · Cited by 3
Diverse oncogenes use common mechanisms to drive growth of major forms of human cancer
Kauko, O., Turunen, M. M., Pihlajamaa, P., Häkkinen, A., Queiroz, R. M. L., Pääkkönen, M., Ventelä, S., Gaetani, M., Lundström, S. L., Murgia, A., et al. (2025) · Science Advances · doi:10.1126/sciadv.adt1798 · Cited by 2
A dual MYC and GSPT1 protein degrader for MYC-driven hematologic malignancies
Nishida, Y., Impedovo, V., Ayoub, E., Baran, N., Scruggs, D. A., Hideaki, M., Khazaei, S., Ostermann, L. B., Kamachi, K., Zhang, L., et al. (2026) · Blood · doi:10.1182/blood.2025030170 · Cited by 2
Genetic Systems to Investigate Regulation of Oncogenes and Tumour Suppressor Genes in Drosophila
Lee, J., Cranna, N. J., Chahal, A., & Quinn, L. M. (2012) · Cells · doi:10.3390/cells1041182 · Cited by 2
Cell cycle dependent genes from the gastric cancer cell MKN45 can affect tumorigenesis.
Chen, L., Lan, B., Chen, X., Li, J., Qu, Y., Yu, B., Yu, Y., Gu, Q., Zhu, Z., & Liu, B. (2011) · PubMed · Cited by 2
Phytochemicals targeting metabolic reprogramming in cancer: an assessment of role, mechanisms, pathways and therapeutic relevancePreprint
Khan, A., Siddiqui, S. I., Husain, S. A., Mazurek, S., & Iqbal, M. A. (2020) · doi:10.22541/au.160684227.70170021/v1 · Cited by 2
Emerging New Pathways in Malignant Neoplasms and Neurodegenerative Disorders: Perspectives for Therapeutics
Wrasidlo, W., & Masliah, E. (2026) · Cells · doi:10.3390/cells15131177 · Cited by 1
Colorectal Cancer Stem Cells
Nangia‐Makker, P., Yu, Y., Farhana, L., Ahmed, K., & Majumdar, A. P. N. (2015) · Springer eBooks · doi:10.1007/978-3-319-21030-8_9 · Cited by 1
Prostate Cancer
Seitzer, N., Reschke, M., Clohessy, J. G., & Pandolfi, P. P. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_33 · Cited by 1
Identification of 5-Thiocyanatothiazol-2-amines Disrupting WDR5-MYC Protein–Protein Interactions
Wang, H., Zhou, Y., Li, L., Cen, J., Wu, Z., Yang, B. K., Zhu, C., Cao, J., Yu, Y., & Chen, W. (2024) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.4c00220 · Cited by 1
Patterns of protein synthesis in the budding yeast cell cycle: variable or constant?
No, E., Blank, H. M., & Polymenis, M. (2024) · Microbial Cell · doi:10.15698/mic2024.08.835 · Cited by 1
Hematological Malignancies and Premalignant Conditions
Reschke, M., Seitzer, N., Clohessy, J. G., & Pandolfi, P. P. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_23 · Cited by 1
Regulation and dysregulation of protein synthesis in cancer cells
Clemens, M. J., Elia, A., & Morley, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.007 · Cited by 1
The Paradox of c-Myc Proto-oncogene and its Diverse Functions
Sarkar, S. (2014) · Cell & Developmental Biology · doi:10.4172/2168-9296.1000145 · Cited by 1
eIF4A dependency: the hidden key to unlock KRAS mutant non-small cell lung cancer’s vulnerability
Casacuberta‐Serra, S., González-Larreategui, Í., & Soucek, L. (2023) · Translational Lung Cancer Research · doi:10.21037/tlcr-23-682 · Cited by 1
ProMPt: A modular preclinical platform for functional modelling of prostate cancer heterogeneity and therapeutic vulnerabilitiesPreprint
Pandell, N., Househam, J., Tartagni, M., Thankamony, A. P., Gabel, F., Rota, R., Flittner, E., Gürel, B., Figueiredo, I., Seed, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.16.688689 · Cited by 1
Myc-mediated control of gene transcription in cancer cells
Gherardi, S. (2010) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/2809
The pharmacology of the sigma-1 receptor.
Brimson, J. M. (2010) · The University of Bath Online Publications Store (The University of Bath)
Translational Control of Cell Proliferation and Viability in Normal and Neoplastic Cells
Avdulov, S. V., Gómez-García, J. R., Bitterman, P. B., & Polunovsky, V. A. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_18
Neuroblastoma: Role of MYCN/Bmi1 Pathway in Neuroblastoma
Kamijo, T. (2011) · Pediatric cancer · doi:10.1007/978-94-007-2418-1_15
Factors affecting the formation, stability, and expression of unintegrated lentiviral vector genomes
Bayer, M. (2010) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/j9mp-1c47
Alterations in the regulatory networks of cellular and molecular events
Thiagalingam, S. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9780511979811.005
β-Catenin Regulation of Adult Skeletal Muscle Plasticity
Wen, Y. (2018) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2018.030
Distinct cellular functional profiles in pan-cancer expression analysis of cancers with alterations in oncogenes c-MYC and n-MYC
Richardson, A. B. (2018)
Biological analysis of the in-vitro effects of homologous recombination inhibition and its use in cancer treatment through synthetic lethality
Balboni, A. (2021) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/9587
eIF6
Biffo, S., Brina, D., & Oliveto, S. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_11
Faculty Opinions recommendation of ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression.
El‐Deiry, W. S., & Ferrarini, I. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736081452.793562850
Descoberta do mecanismo de ação de novas drogas por meio da análise do perfil transcriptômico e estudos préclínicos em leucemias agudas
Cury, N. M. (2019) · doi:10.47749/t/unicamp.2019.1235606
Multiple latent clustering model for the inference of RNA life-cycle kinetic rates from sequencing data
Mastrantonio, G., Bibbona, E., & Furlan, M. (2024) · Annals of Applied Statistics · doi:10.1214/24-aoas1945
Dual MYC and GSPT1 Protein Degrader for MYC-Driven CancersPreprint
Nishida, Y., Impedovo, V., Ayoub, E., Baran, N., Scruggs, D. A., Mizuno, H., Khazaei, S., Ostermann, L. B., Singh, S., Bedoy, A. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.24.650490
Ribosomal RNA Degradation (RNA Disruption) in Tumour Cells: Mechanistic Insights and Potential Clinical Utility
Parissenti, A. M., Noubir, S., Pritzker, L. B., Kovala, A. T., Lannér, C., Lemon, J. A., Onayemi, T., Pk, S., Thériault, G., Trudeau, M., et al. (2025) · Cancers · doi:10.3390/cancers17172769
Additional file 1 of Marinopyrrole derivative MP1 as a novel anti-cancer agent in group 3 MYC-amplified Medulloblastoma
Coulter, D., Chhonker, Y. S., Kumar, D., Kesherwani, V., Aldhafiri, W. N., McIntyre, E. M., Alexander, G. R., Ray, S., Joshi, S. S., Li, R., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24979588
Additional file 1 of Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma
Kling, M. J., Griggs, C. N., McIntyre, E. M., Alexander, G. R., Ray, S., Challagundla, K. B., Joshi, S. S., Coulter, D. W., & Chaturvedi, N. K. (2021) · Figshare · doi:10.6084/m9.figshare.16682829
dMyc suppresses CTG-induced cytotoxicity in the Drosophila model of DM1 by reducing autophagy and cell death
Chakraborty, D., Singh, N. T., Borthakur, S., & Singh, M. D. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03123-w
MicroRNA ‐15a/16 regulate protein metabolism and are associated with clinical outcomes in pancreatic ductal adenocarcinoma
Ryan, P. J., Guerra, B. C., Nghiem, P. P., Riechman, S. E., Janini‐Gomes, M., & Fluckey, J. D. (2026) · Physiological Reports · doi:10.14814/phy2.71015
LARP1 at the nexus of oncogenic MYC and mTOR signaling
Curdy, N., & Topisirović, I. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2619021123
BindingDB Entry 50002796: Synthetic molecules for disruption of the MYC protein-protein interface.
BindingDB (2020) · UC San Diego · doi:10.7270/q2fj2kdb
Variation of the PALB2 and PTEN Genes and eIF4E Protein Expression as Prognostic Factors in Breast Cancer
Heikkinen, T. (2013) · Työväentutkimus Vuosikirja
Development of Inhibitors and Assay Methods for Histone Acetyltransferases
Wu, J. (2022) · Digital Archive @ GSU · doi:10.57709/1966306

Authors: Ruggero, D.
Affiliations: University of California, San Francisco (US)
Corresponding author: Ruggero, Davide
ORCID: Ruggero, Davide
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2009-11-30
Volume: 69
Issue: 23
Pages: 8839-8843
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-09-1970
PMC: PMC2880919
OpenAlex: W2093199938
Cited by: 186
References: 42
Citations by year: 2026: 7 · 2025: 7 · 2024: 13 · 2023: 10 · 2022: 8 · 2021: 12 · 2020: 12 · 2019: 7 · 2018: 13 · 2017: 6 · 2016: 5 · 2015: 10 · 2014: 18 · 2013: 13 · 2012: 19
FWCI: 1.15
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Sandler Foundation
National Institutes of Health (NIH-R01)
University of California, San Francisco
National Heart, Lung, and Blood Institute (R01HL085572)
National Cancer Institute (R01CA140456)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords: MYC oncogene, translational regulation, protein synthesis, ribosomal proteins, translation initiation factors, ribosomal DNA, genomic instability, cell cycle progression, tumor initiation, translation machinery
MeSH terms: Animals, Humans, Neoplasms, Protein Biosynthesis, Gene Expression Regulation, Neoplastic, Genes, myc, Proto-Oncogene Proteins c-myc

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Role of Myc-Induced Protein Synthesis in Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks